$IOVA was Granted FDA Fast Track Designation for LN145 for Cervical Cancer

$IOVA was Granted FDA Fast Track Designation for LN-145 for Cervical Cancer

07:05 EST 26 Feb 2019 | Odi Bruckman

$IOVA was Granted FDA Fast Track Designation for LN-145 for Cervical Cancer

More From BioPortfolio on "$IOVA was Granted FDA Fast Track Designation for LN-145 for Cervical Cancer"